May 8 (Reuters) - AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic. The company also ...
AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision. It said the rise of new coronavirus variants meant demand had shifted to the newer updated vaccines.
Drugmaker AstraZeneca is reportedly pulling its COVID-19 vaccine from global markets due to a surplus of updated alternatives that have led to a drop-off in demand. The news was first reported by The ...
After more than three billion doses, the Oxford-AstraZeneca Covid vaccine is being withdrawn. AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision.
The new development follows the company’s voluntary withdrawal of marketing authorisation for the vaccine in the European Union. Credit: rarrarorro / Shutterstock.com. AstraZeneca has begun the global ...
The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical giant admitted for the first time in court documents that it can cause a rare and dangerous side ...
(Reuters) -AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic. The company also said it ...
In March 2024, AstraZeneca requested that the authorization for their COVID-19 vaccine be withdrawn by the European Medicines Agency. On May 7, 2024, the company began to withdraw the vaccine ...